Article information
Full text is only aviable in PDF
Bibliografía
[1.]
National Asthma Education and Prevention Program Expert Panel Report 2.
Guidelines for the diagnosis and management of asthma,
[2.]
British Asthma Guidelines Coordinating Committee.
British guidelines on asthma management, 1995 review and position statement.
Thorax, 52 (1997), pp. S1-S24
[3.]
B.E. Brenner.
Where have we been? The history of acute asthma.
Emergency asthma, pp. 1-31
[4.]
R.M. Nowak.
National and international guidelines for the emergency management of adult asthma in North American emergency departments.
Ann Emerg Med, 34 (1999), pp. S13
[5.]
A. Travers, B.H. Rowe, S. Clark, J.r. Camargo CA.
The use of systemic beta-agonists in acute asthma in North American emergency departments [abstract].
Ann Emerg Med, 34 (1999), pp. S13
[6.]
A. Travers, A.P. Jones, K. Kelly, S.J. Barker, C.A. J.r. Camargo, B.H. Rowe.
Intravenous beta2-agonists for acute asthma in the emergency department [Cochrane Review].
The Cochrane Library, Issue 4,
[7.]
G.J. Browne, A.S. Penna, X. Phung, M. Soo.
Randomized trial of intravenous albuterol in early management of acute severe asthma in children.
Lancet, 349 (1997), pp. 301-305
[8.]
M.C. Papo, J. Frank, A.E. Thompson.
A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children.
Crit Care Med, 21 (1993), pp. 479-486
[9.]
H. Khine, S.M. Fuchs, A.L. Saville.
Continuous vs intermittent nebulized albuterol for emergency management of asthma.
Acad Emerg Med, 3 (1996), pp. 1019-1024
[10.]
A. Colacone, N. Wolkove, E. Stern, M. Afilalo, T.M. Rosenthal, H. Kreisman.
Continuous nebulization of albuterol (Salbutamol) in acute asthma.
Chest, 97 (1990), pp. 693-697
[11.]
R.Y. Lin, D. Sauter, T. Newman, J. Sirleaf, J. Walters, M. Ravakol.
Continuous versus intermittent albuterol nebulization in the treatment of acute asthma.
Ann Emerg Med, 22 (1993), pp. 1847-1853
[12.]
G.S. Rudnitsky, R.S. Eberlein, J.M. Schoffstall, J.E. Mazur, W.H. Spivey.
Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department.
Ann Emerg Med, 22 (1993), pp. 1842-1846
[13.]
C. Reisner, A. Kotch, G. Dworkin.
Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized, prospective study.
Ann Allergy Asthma Immunol, 75 (1995), pp. 41-47
[14.]
M. Shrestha, K. Bidadi, S. Gourlay, J. Hayes.
Continuous vs intermittent albuterol, at high and low doses, in the treatment of severe asthma in adults.
Chest, 110 (1996), pp. 42-47
[15.]
L. BesbesOuanes, S. Nouira, S. Elatrous, J. Knani, M. Boussarsar, F. Abroug.
Continuous versus intermittent nebulization of Salbutamol in acute severe asthma. A randomized, controlled trial.
Ann Emerg Med, 36 (2000), pp. 198-203
[16.]
M.A. Gibbs, C.A. Camargo, B.H. Rowe, R.A. Silverman.
State of the art: therapeutic controversies in severe acute asthma.
Am Emerg Med, 7 (2000), pp. 800-815
[17.]
S.A. Quadrelli, A.J. Roncoroni, D.M. Pinna.
Farmacos betaagonistas en el tratamiento del asma bronquial.
Arch Bronconeumol, 36 (2000), pp. 471-486
[18.]
P. Koning.
Spacer devices used with meter-dose inhalers: breakthrough or gimmick?.
Chest, 88 (1985), pp. 276-284
[19.]
R.E. Ruffin, J.M. Montgomery, M.T. Newhouse.
Site of beta-adrenergics receptors in the respiratory tract: use of fenoterol administered by two methods.
Chest, 74 (1978), pp. 256-260
[20.]
A. Santolicandro, C. Giuntini.
Patterns of deposition of labeled monodispersed aerosols in obstructive lung disease.
J Nucl Med Allied Sci, 23 (1979), pp. 115-127
[21.]
P.E. Morrow.
Aerosol characterization and deposition.
Am Rev Respir Dis, 110 (1979), pp. 88-99
[22.]
J.D. Brain, P.A. Valberg.
Deposition of aerosol in the respiratory tract.
Am Rev Respir Dis, 120 (1979), pp. 1325-1373
[23.]
M.B. Dolovich, R.E. Ruffin, R. Roberts, M.T. Newhouse.
Optimal delivery of aerosols from metered dose inhalers.
Chest, 80 (1981), pp. 911-915
[24.]
P.E. Morrow.
An evaluation of the physical properties of monodisperse and heterodisperse aerosols used in the assessment of bronchial function.
Chest, 80 (1981), pp. 809-813
[25.]
M.M. Clay, D. Pavia, S.P. Newman, S.W. Clarke.
Assessment of jet nebulizers for lung aerosol therapy.
Lancet, 2 (1983), pp. 592-594
[26.]
M.M. Clay, D. Pavia, S.P. Newman, T. Lennard-Jones, S.W. Clarke.
Factors influencing the size distribution of aerosols from jet nebulizers.
Thorax, 38 (1983), pp. 755-759
[27.]
B.L. Laube.
In vivo measurements of aerosol dose and distribution: clinical relevance.
J Aerosol Med, 9 (1996), pp. S77-S91
[29.]
S.P. Newman, D. Pavia, F. Moren, N.F. Sheahan, S.W. Clarke.
Deposition of pressurized aerosols in the human respiratory tract.
Thorax, 36 (1981), pp. 52-55
[30.]
S.P. Newman, D. Pavia, N. Garland, S.W. Clarke.
Effects of various inhalation modes on the deposition of radioactive pressurized aerosols.
Eur J Resp Dis, 119 (1982), pp. 57-65
[31.]
S.P. Newman.
Aerosol deposition considerations in inhalation therapy.
Chest, 88 (1985), pp. s152-s160
[32.]
M. Newhouse, M. Dolovich.
Current concepts: control of asthma by aerosols.
N Engl J Med, 315 (1986), pp. 870-874
[33.]
G.F. Alvine, P. Rodgers, K.M. Fitzsimmons, R.C. Ahrens.
Disposable jet nebulizers.
How reliable are they? Chest, 101 (1992), pp. 316-319
[34.]
D.T. Loffer, D. Ikle, H.S. Nelson.
A comparison of commercial jet nebulizers.
Chest, 106 (1994), pp. 1788-1793
[35.]
D. Hess, D. Fisher, P. Williams, S. Pooler, R.M. Kacmarek.
Medication nebulizer performance: effects of diluent volume, nebulizer flow, and nebulizer brand.
Chest, 110 (1996), pp. 498-505
[36.]
M.A. Dolovich.
Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung.
Respir Care, 45 (2000), pp. 597-608
[37.]
M.L. Everald, J.G. Hardy, A.D. Milner.
Comparison of nebulized aerosol deposition in the lungs of healthy adults following oral and nasal inhalation.
Thorax, 48 (1993), pp. 1045-1046
[38.]
S.P. Newman, S.W. Clarke.
Therapeutic aerosols 1. Physical and practical considerations.
Thorax, 38 (1983), pp. 881-886
[39.]
A.C. Jasper, Z. Mohsenifar, S. Kahan, H.S. Goldberg, S.K. Koerner.
Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients.
Chest, 91 (1987), pp. 614-618
[40.]
D.L. Bowton, W.M. Goldsmith, E.F. Haponik.
Substitution of metered- dose inhalers for hand-held nebulizers. Success and cost savings in a large acute-care hospital.
Chest, 101 (1992), pp. 305-308
[41.]
C. O'Collaghan.
In vitro performance of plastic spacer devices [review].
J Aerosol Med, 10 (1997), pp. S31-S35
[42.]
P.W. Barry, C. O'Callaghan.
The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the nebuhaler.
Br J Clin Pharmacol, 40 (1995), pp. 76-78
[43.]
J.H. Wildhaber, N.D. Dore, J.M. Wilson, S.G. Devadason, P.N. LeSoef.
Inhalation therapy in asthma: nebulizer or pressurized meter-dose inhaler with holding chamber? In vivo comparison of lung deposition in children.
J Pediatr, 136 (1999), pp. 28-33
[44.]
M.O. Turner, A. Patel, S. Ginsburg, J.M. FitzGerald.
Bronchodilator delivery in acute airflow obstruction. A meta-analysis.
Arc Intern Med, 157 (1997), pp. 1736-1744
[45.]
C.J. Cates, B.H. Rowe.
Holding chambers versus nebulisers for betaagonist treatment of acute asthma [Cochrane Review]. The Cochrane Library, Issue 4,
[46.]
G. Rodrigo, C. Rodrigo.
Comparison of salbutamol delivered by nebulizer or metereddose inhaler with a pear-shaped spacer in acute asthma.
Curr Ther Res, 54 (1993), pp. 797-808
[47.]
C. Rodrigo, G. Rodrigo.
Salbutamol treatment of acute severe asthma in the ED: MDI versus hand-held nebulizer.
Am J Emerg Med, 16 (1998), pp. 637-642
[48.]
M.T. Newhouse.
Asthma therapy with aerosols: are nebulizers obsolete? A continuing controversy.
J Pediatr, 135 (1999), pp. 5-8
[49.]
American Association for Respiratory Care and the American Respiratory Care Foundation.
Consensus statement: Aerosols and delivery devices.
Respir Care, 45 (2000), pp. 589-596
[50.]
G. Rodrigo, C. Rodrigo.
Tratamiento de la crisis asmatica: comparacion entre fenoterol y Salbutamol en altas dosis administradas mediante inhalador de dosis medida con inhalocamara y aminofilina intravenosa.
Pac Critico, 4 (1991), pp. 194-209
[51.]
G. Rodrigo, C. Rodrigo.
Assessment of the patient with acute asthma in the emergency department: a factor analytic study.
Chest, 104 (1993), pp. 1325-1328
[52.]
G. Rodrigo, C. Rodrigo.
A new indez for early prediction of hospitalization in patients with acute asthma.
Am J Emerg Med, 15 (1997), pp. 8-13
[53.]
G. Rodrigo, C. Rodrigo.
Early prediction of poor response acute asthma patients in the emergency department.
Chest, 114 (1999), pp. 1016-1021
[54.]
R.M. Nowak.
Inhaled beta-agonists and acute asthma.
Am J Emerg Med, 13 (1995), pp. 94-96
[55.]
E.H. Walters, A. Cockroft, T. Griffiths, K. Rocchiccioli, B.H. Davies.
Optimal dose of Salbutamol respiratory solution: comparison of three doses with plasma levels.
Thorax, 36 (1981), pp. 625-626
[56.]
B.J. Lipworth, R.A. Clark, D.P. Dhillon, R.A. Brown, D.G. McDevitt.
Betaadrenoceptor responses to high doses of inhaled Salbutamol in patients with bronchial asthma.
Br J Clin Pharmacol, 26 (1988), pp. 527-533
[57.]
D.C. Stanescu.
High doses of sympathomimetics in severe bronchial asthma.
Eur Respir J, 2 (1989), pp. 597-598
[58.]
J. Britton, A. Tattersfield.
Comparison of cumulative and noncumulative techniques to measure dose-response curves for beta-agonists in patients with asthma.
Thorax, 39 (1984), pp. 597-599
[59.]
G. Rodrigo, C. Rodrigo.
Metered dose inhaler Salbutamol treatment of asthma in the ED: comparison of two doses with plasma levels.
Am J Emerg Med, 14 (1996), pp. 144-150
[60.]
L. Strauss, R. Hejal, O. Galan, L. Dixon, J.r. McFadden ER.
Observations on the effects of aerosolized albuterol in acute asthma.
Am J Respir Crit Care Med, 155 (1997), pp. 454-458
[61.]
C. Rodrigo, G. Rodrigo.
Therapeutic response pattern to high and cumulative doses of Salbutamol in acute severe asthma.
Chest, 113 (1998), pp. 593-598
[62.]
E.R. McFadden, L. Strauss, R. Hejal, G. Galan.
Dizon L Comparison of rwo dosage regimen of albuterol in acute asthma.
Am J Med, 105 (1998), pp. 12-17
[63.]
L.H. Plotnick, F.M. Ducharme.
Should inhaled anticholinergics be added to β2 agonists for treating acute childhood and adolescent asthma? A systematic review.
Bmj, 317 (1998), pp. 971-977
[64.]
G.J. Rodrigo, C. Rodrigo, O. Burschtin.
Ipratropium bromide in acute adult severe asthma: a meta-analysis of randomized controlled trials.
Am J Med, 107 (1999), pp. 363-370
[65.]
G.J. Rodrigo, C. Rodrigo.
First-line therapy for adults acute asthma patients with a multiple dose protocol of ipratropium bromide plus albuterol on the emergency department.
Am J Respir Crit Care Med, 161 (2000), pp. 1862-1868
[66.]
G. Rodrigo, C. Rodrigo.
Inhaled flunisolide for acute severe asthma.
Am J Respir Crit Care Med, 157 (1998), pp. 698-703
[67.]
H. Yanmaguchi, J.R. McCullough.
S-albuterol exacerbates calcium responses to carbacol in airway smooth muscle cells.
Clin Rev Allergy Immunol, 14 (1996), pp. 47-55
[68.]
T. Walle, E.A. Eaton, U.K. Walle, G. Pesola.
Stereoselective metabolism of RS-albuterol in humans.
Clin Rev Allergy Immunol, 14 (1996), pp. 101-113
[69.]
H.S. Nelson, G. Bensch, W.W. Pleskow, R. DiSantostefano, S. DeGraw, D.S. Reasner, et al.
Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma.
J Allergy Clin Immunol, 102 (1998), pp. 943-952
[70.]
S. Larsson, N. Svedmyr.
Bronchodilating effects and side effects of beta-adrenoreceptor stimulants by different modes of administration.
Am Rev Respir Dis, 116 (1977), pp. 861-869
[71.]
M. Kung, S.W. Croley, B.A. Phillips.
Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol: influence of mouth rinsing and gargling.
Chest, 91 (1987), pp. 382-387
[72.]
D.A. Jerrad, J. Olshhaker, E. Welebob, V. Caraballo, F. Hooper.
Efficacy and safety of a rapid-sequence metaproterenol protocol in the treatment of acute adult asthma.
Am J Emerg Med, 13 (1995), pp. 392-395
[73.]
A. Tal, H. Pasterkamp, F. Leahy.
Arterial oxygen desaturation following salbutamol inhalation in acute asthma.
Chest, 86 (1984), pp. 868-869
[74.]
J. Roca, L.l. Ramis, R. Rodríguez Roisin, E. Ballester, J.M. Montserrat, P.D. Wagner.
Serial relationships between ventilation-perfusion inequality and spirometry in acute severe asthma requiring hospitalization.
Am Rev Respir Dis, 137 (1988), pp. 1055-1061
[75.]
R. Rodríguez Roisin.
acute severe asthma: pathophysiology and pathobiology of gas exchange abnormalities.
Eur Respir J, 10 (1997), pp. 1359-1371
[76.]
M.I. Brown, D.C. Brown, M.B. Murphy.
Hypokalemia from beta2-receptor stimulation by circulating epinephrine.
N Engl J Med, 309 (1983), pp. 1414-1419
[77.]
M. Scheinin, M. Koulu, E. Larikainene, H. Allonen.
Hypokalemia and other nonbronchial effects of inhaled fenoterol and Salbutamol: a placebo controlled dose-response study in healthy volunteers.
Br J Clin Pharmacol, 24 (1987), pp. 645-653
[78.]
J. Crane, C. Burguess, R. Beasley.
Cardiovascular and hypokalaemic effects of inhaled Salbutamol fenoterol and isoprenaline.
Thorax, 44 (1989), pp. 136-140
[79.]
R.Y. Lin, A.J. Smith, P. Hergenroeder.
High serum albuterol levels and tachycardia in adult ashtmatics treated with high-dose continuously aerosolized albuterol.
Chest, 103 (1993), pp. 221-225
Copyright © 2002. Sociedad Española de Neumología y Cirugía Torácica
